Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Laboratory evaluations were completed at Visit 1 and Visit 8 which included hemoglobin A1C, fasting insulin, fasting blood glucose and lipid panel (total cholesterol, LDL, HDL, triglycerides)
Liraglutide Versus Glimepiride Monotherapy for Type 2 Diabetes (LEAD-3 Mono): A Randomised, 52-Week, Phase III, Double-Blind, Parallel-Treatment Trial
Warnings ** This statement has not been evaluated by the Food and Drug Administration
This table outlines the major GLP-1 receptor agonists through the mid-2010s, including their approval dates, dosing schedules, and distinguishing features
US$ 21.59
US$ 23.28
US$ 27.08
US$ 25.49
